Clinical Trial Update: Immunoadsorption in Patients With Pulmonary Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 immunoadsorption clinical trial in patients with pulmonary hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: University Medicine Greifswald | Conditions: Pulmonary Hypertension, Pulmonary Resistance | Phase 1, Phase 2 | Status: WITHDRAWN